$9.96
-0.29-2.83%
At close: -
$9.96
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
UroGen Pharma Insider Trading Activity | NASDAQ:URGN | Benzinga
Track the latest UroGen Pharma insider trading activity. Stay informed on recent buys, sells, and market impact for UroGen Pharma stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are UroGen Pharma Ltd Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for UroGen Pharma Ltd
Shares Outstanding
46.094M
Insider Shares Owned
1.033M
Insider Percentage Owned
2.24%
Institutional Shares Held
6.998M
Institutional Percentage Held
15.2%
| Feb 04, 2025 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 3.45K | $11.14 | -$50.70K | SELL-OPTIONS | 2.38% | 148.54K | Jan 31 | View |
| Feb 04, 2025 | Jason D. Smith Attorney-in-Fact | GENERAL COUNSEL | 7.29K | $11.14 | -$82.20K | SELL-OPTIONS | 28.89% | 32.51K | Jan 31 | View |
| Sep 12, 2024 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 807.00 | $13.08 | -$11.24K | SELL-OPTIONS | 0.56% | 145.09K | Sep 09 | View |
| Sep 12, 2024 | Jason D. Smith Attorney-in-Fact | GENERAL COUNSEL | 1.81K | $13.08 | -$19.89K | SELL-OPTIONS | 7.74% | 25.23K | Sep 09 | View |
| Jun 11, 2024 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 4.85K | $13.08 | -$67.40K | SELL-OPTIONS | 3.48% | 144.28K | Jun 10 | View |
| Mar 20, 2024 | Mark Schoenberg | CHIEF MEDICAL OFFICER | -12.00K | $14.05 | -$168.60K | SELL | -7.92% | 139.44K | Mar 18 | View |
| Feb 02, 2024 | Jason D. Smith Attorney-in-Fact | GENERAL COUNSEL | 5.01K | $15.74 | -$78.59K | SELL-OPTIONS | 27.20% | 23.41K | Jan 31 | View |
| Feb 02, 2024 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 2.88K | $15.74 | -$59.64K | SELL-OPTIONS | 1.94% | 151.44K | Jan 31 | View |
| Sep 05, 2023 | Jason D. Smith Attorney-in-Fact | GENERAL COUNSEL | 4.53K | $18.01 | -$68.44K | SELL-OPTIONS | 32.68% | 18.41K | Aug 31 | View |
| Feb 02, 2023 | Jason D. Smith Attorney-in-Fact | GENERAL COUNSEL | 1.70K | $10.12 | -$16.56K | SELL-OPTIONS | 13.94% | 13.87K | Jan 31 | View |
| Feb 02, 2023 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 1.93K | $10.12 | -$19.23K | SELL-OPTIONS | 1.32% | 148.56K | Jan 31 | View |
| Nov 02, 2022 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 242.00 | $11.85 | -$3.06K | SELL-OPTIONS | 1.02% | 23.95K | Oct 31 | View |
| Sep 02, 2022 | Jason D. Smith Attorney-in-Fact | GENERAL COUNSEL | 4.73K | $7.21 | -$26.00K | SELL-OPTIONS | 63.46% | 12.18K | Aug 31 | View |
| Aug 25, 2022 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 241.00 | $7.81 | -$2.02K | SELL-OPTIONS | 1.03% | 23.71K | Jul 31 - Aug 01 | View |
| May 03, 2022 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 246.00 | $6.62 | -$1.68K | SELL-OPTIONS | 1.06% | 23.47K | Apr 30 | View |
| Feb 02, 2022 | Jason D. Smith Attorney-in-Fact | GENERAL COUNSEL | 419.00 | $7.58 | -$3.14K | SELL-OPTIONS | 5.96% | 7.45K | Jan 31 | View |
| Feb 02, 2022 | Molly Henderson | CHIEF FINANCIAL OFFICER | 335.00 | $7.58 | -$2.51K | SELL-OPTIONS | 6.82% | 5.25K | Jan 31 | View |
| Feb 02, 2022 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 1.13K | $7.58 | -$10.41K | SELL-OPTIONS | 5.10% | 23.22K | Jan 31 | View |
| Feb 02, 2022 | Elizabeth Barrett | CHIEF EXECUTIVE OFFICER | 10.14K | $7.58 | -$62.12K | SELL-OPTIONS | 3.40% | 308.36K | Jan 31 | View |
| Jan 28, 2022 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 98.00 | $8.09 | -$897.99 | SELL-OPTIONS | 0.45% | 22.09K | Jan 26 | View |
| Jan 07, 2022 | Elizabeth Barrett | CHIEF EXECUTIVE OFFICER | 58.72K | $9.15 | -$429.76K | SELL-OPTIONS | 24.52% | 298.22K | Jan 03 - Jan 04 | View |
| Dec 02, 2021 | Jason Smith Attorney-in-Fact | GENERAL COUNSEL | 4.53K | $12.03 | -$45.75K | SELL-OPTIONS | 181.20% | 7.03K | Nov 30 | View |
| Dec 02, 2021 | Molly Henderson | CHIEF FINANCIAL OFFICER | 2.41K | $12.03 | -$31.12K | SELL-OPTIONS | 96.52% | 4.91K | Nov 30 | View |
| Nov 19, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 160.00 | $13.10 | $2.10K | BUY | 0.73% | 22.00K | Nov 18 | View |
| Nov 02, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 242.00 | $17.16 | -$4.43K | SELL-OPTIONS | 1.12% | 21.84K | Oct 31 - Nov 01 | View |
| Oct 28, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 101.00 | $16.32 | -$1.75K | SELL-OPTIONS | 0.47% | 21.59K | Oct 26 - Oct 27 | View |
| Aug 03, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 257.00 | $15.64 | -$3.80K | SELL-OPTIONS | 1.21% | 21.49K | Jul 31 - Aug 02 | View |
| Jul 28, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | -311.00 | $15.30 | -$1.58K | SELL | -1.47% | 20.82K | Jul 26 | View |
| May 18, 2021 | Molly Henderson | CHIEF FINANCIAL OFFICER | 2.50K | $15.85 | $39.63K | BUY | ∞ | 2.50K | May 17 | View |
| May 18, 2021 | Jason D. Smith | GENERAL COUNSEL | 2.50K | $15.71 | $39.27K | BUY | ∞ | 2.50K | May 17 | View |
| May 04, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 257.00 | $20.00 | -$4.86K | SELL-OPTIONS | 1.23% | 21.13K | Apr 30 | View |
| Apr 27, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 120.00 | $19.63 | -$1.75K | SELL-OPTIONS | 0.58% | 20.88K | Apr 26 | View |
| Feb 02, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 924.00 | $22.07 | -$23.75K | SELL-OPTIONS | 4.66% | 20.75K | Jan 31 | View |
| Jan 26, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 108.00 | $22.12 | -$2.21K | SELL-OPTIONS | 0.55% | 19.83K | Jan 26 | View |
| Dec 15, 2020 | Elizabeth Barrett | — | 10.00K | $18.50 | $185.00K | PURCHASE | 4.56% | 229.12K | Dec 14 | View |
| Dec 07, 2020 | Mark Schoenberg | — | 380.00 | $19.85 | -$13.14K | OPTION EXERCISE | 1.96% | 19.72K | Dec 04 | View |
| Oct 28, 2020 | Mark Schoenberg | — | 107.00 | $20.95 | -$2.12K | OPTION EXERCISE | 0.56% | 19.34K | Oct 26 | View |
| Oct 16, 2020 | PETER PFREUNDSCHUH | — | 2.52K | $21.77 | -$52.25K | OPTION EXERCISE | 31.91% | 10.40K | Oct 15 | View |
| Sep 08, 2020 | Mark Schoenberg | — | 693.00 | $20.20 | -$7.03K | OPTION EXERCISE | 3.74% | 19.24K | Sep 04 | View |
| Sep 01, 2020 | Peter Pfreundschuh Attorney-in-Fact | — | 533.00 | $22.82 | -$11.62K | OPTION EXERCISE | 7.25% | 7.89K | Sep 01 | View |
| Jul 28, 2020 | Peter Pfreundschuh Attorney-in-Fact | — | 276.00 | $23.51 | -$3.31K | OPTION EXERCISE | 3.90% | 7.36K | Jul 26 - Jul 27 | View |
| Jul 28, 2020 | Mark Schoenberg | — | 139.00 | $23.51 | -$1.65K | OPTION EXERCISE | 0.76% | 18.54K | Jul 26 - Jul 27 | View |
| Jun 05, 2020 | Mark Schoenberg | — | 693.00 | $27.51 | -$9.60K | OPTION EXERCISE | 3.91% | 18.40K | Jun 04 | View |
| May 20, 2020 | Peter Pfreundschuh Attorney-in-Fact | — | 683.00 | $25.07 | -$8.98K | OPTION EXERCISE | 10.68% | 7.08K | May 20 | View |
| Apr 28, 2020 | Mark Schoenberg | — | 138.00 | $24.35 | -$1.70K | OPTION EXERCISE | 0.79% | 17.71K | Apr 26 - Apr 27 | View |
| Apr 28, 2020 | Peter Pfreundschuh Attorney-in-Fact | — | 276.00 | $24.35 | -$3.43K | OPTION EXERCISE | 4.51% | 6.40K | Apr 26 - Apr 27 | View |
| Apr 28, 2020 | Stephen Mullennix | — | 272.00 | $24.35 | -$3.53K | OPTION EXERCISE | 2.77% | 10.08K | Apr 26 - Apr 27 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.